255 related articles for article (PubMed ID: 24147739)
1. S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2.
García E; Santana-Martínez R; Silva-Islas CA; Colín-González AL; Galván-Arzate S; Heras Y; Maldonado PD; Sotelo J; Santamaría A
Free Radic Res; 2014 Feb; 48(2):159-67. PubMed ID: 24147739
[TBL] [Abstract][Full Text] [Related]
2. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
3. S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice.
Rojas P; Serrano-García N; Medina-Campos ON; Pedraza-Chaverri J; Maldonado PD; Ruiz-Sánchez E
J Nutr Biochem; 2011 Oct; 22(10):937-44. PubMed ID: 21190833
[TBL] [Abstract][Full Text] [Related]
4. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway.
Colín-González AL; Luna-López A; Königsberg M; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2014 Feb; 260():130-9. PubMed ID: 24361737
[TBL] [Abstract][Full Text] [Related]
5. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
[TBL] [Abstract][Full Text] [Related]
6. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss.
Grünblatt E; Mandel S; Maor G; Youdim MB
J Neurochem; 2001 Apr; 77(1):146-56. PubMed ID: 11279270
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
8. S-allyl cysteine activates the Nrf2-dependent antioxidant response and protects neurons against ischemic injury in vitro and in vivo.
Shi H; Jing X; Wei X; Perez RG; Ren M; Zhang X; Lou H
J Neurochem; 2015 Apr; 133(2):298-308. PubMed ID: 25393425
[TBL] [Abstract][Full Text] [Related]
9. 17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult.
Tripanichkul W; Sripanichkulchai K; Duce JA; Finkelstein DI
Brain Res; 2007 Aug; 1164():24-31. PubMed ID: 17640623
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Imai Y; Kato H; Araki T
Neurol Res; 2004 Sep; 26(6):644-57. PubMed ID: 15327754
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
Ren Y; Ye D; Ding Y; Wei N
Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
[No Abstract] [Full Text] [Related]
13. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
15. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of naringenin against MPTP-induced oxidative stress.
Sugumar M; Sevanan M; Sekar S
Int J Neurosci; 2019 Jun; 129(6):534-539. PubMed ID: 30433834
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220.
Lee JA; Son HJ; Choi JW; Kim J; Han SH; Shin N; Kim JH; Kim SJ; Heo JY; Kim DJ; Park KD; Hwang O
Neurochem Int; 2018 Jan; 112():96-107. PubMed ID: 29158022
[TBL] [Abstract][Full Text] [Related]
19. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]